COMMONWEALTH EQUITY SERVICES, LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 80 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$54,000
-20.6%
12,955
+0.6%
0.00%
Q2 2021$68,000
+15.3%
12,880
+0.7%
0.00%
Q1 2021$59,000
+34.1%
12,785
-5.1%
0.00%
Q4 2020$44,000
-2.2%
13,472
-1.6%
0.00%
Q3 2020$45,000
-11.8%
13,692
-9.9%
0.00%
Q2 2020$51,000
-13.6%
15,192
-2.6%
0.00%
Q1 2020$59,000
-47.8%
15,592
-17.0%
0.00%
Q4 2019$113,000
-16.9%
18,792
+3.9%
0.00%
-100.0%
Q3 2019$136,000
-25.3%
18,092
+34.1%
0.00%0.0%
Q2 2019$182,000
+333.3%
13,492
-6.4%
0.00%
Q4 2018$42,00014,4200.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Ground Swell Capital, LLC 25,445$19,0000.05%
ETF MANAGERS GROUP, LLC 2,258,970$1,654,0000.05%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 116,780$85,0000.02%
GSA CAPITAL PARTNERS LLP 131,036$96,0000.01%
Bernardo Wealth Planning LLC 30,469$20,0000.01%
PCG Wealth Advisors, LLC 15,200$12,0000.00%
Penserra Capital Management LLC 212,298$155,0000.00%
ZEKE CAPITAL ADVISORS, LLC 49,700$36,0000.00%
King Wealth Management Group 16,000$12,0000.00%
Vident Investment Advisory, LLC 105,398$77,0000.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders